Randomisierte Studie zur Wirksamkeit von FOLFIRI in Kombination mit Cetuximab vs. Bevacizumab in der Erstlinien-Behandlung des metastasierten kolorektalen Karzinoms English translation: Randomised study for efficiency of FOLFIRI in combination with Cetuximab vs. Bevacizumab in first-line-therapy of metastatic colorectal cancer

ABSTRACT: Primary objectives: Comparative validation of antitumor efficacy measured by objective remissionrate defined by RECIST-criteria (OR= CR+ PR), assessed within intent-to-treat-collective. Primary endpoints: Progression of metastatic colorectal cancer or patient’s death

DISEASE(S): Metastatic Colorectal Cancer

PROVIDER: 2520341 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR